The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
Robert Farber(Neurocrine Biosciences (United States)), Christopher Brien(Neurocrine Biosciences (United States)), Eric Jen(Neurocrine Biosciences (United States)), Rahul Dhanda, Christopher J. Evans(University of Southern California), Donald E. Stull(IQVIA (United States)), Charles Yonan(Neurocrine Biosciences (United States)), Morgan Bron(Neurocrine Biosciences (United States)), Brooke Witherspoon
Cited by 5
Related Papers
Optimal recall periods for patient-reported outcomes: challenges and potential solutions
|Current Medical Research and Opinion|2009|413
Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice
|Nature Medicine|1996|259
Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors
|Journal of Neuroscience|2003|214
Measurement and the Analysis of Burden
|Research on Aging|1985|142